Zhiyabio

致雅生物

Zhiyabio

Enterprise Software/SaaS

Zhiya Biotech develops novel pharmaceutical-grade lactose excipients and generic drugs. Building on an earlier curcumin solid lipid nanoparticle dry-powder inhaler project, the company plans to replace conventional lactose in the original formulation with its proprietary flower-shaped lactose…

Latest round: Pre Series A (2024)

Source: ChinaBulls — chinabulls.com

Last updated 2024-07-01